INTERNATIONAL PATENT: NEW YORK UNIVERSITY IN ABU DHABI CORPORATION FILES APPLICATION FOR "RGD-PEPTIDE MODIFIED COVALENT ORGANIC FRAMEWORKS FOR TARGETED CANCER THERAPY"

GENEVA, Sept. 29 -- NEW YORK UNIVERSITY IN ABU DHABI CORPORATION (Saadiyat IslandP.O. Box 129188Abu Dhabi) filed a patent application (PCT/IB2025/052878) for "RGD-PEPTIDE MODIFIED COVALENT ORGANIC FRAMEWORKS FOR TARGETED CANCER THERAPY" on Mar 19, 2025. With publication no. WO/2025/196660, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TRABOLSI, Ali (c/o New York University Abu DhabiSaddiyat IslandPO Box 129188Abu Dhabi), BENYETTOU, Farah (c/o New York University Abu DhabiSaddiyat IslandPO Box 129188Abu Dhabi)

Abstract:...